Click on the paperclip at the top of the page to add, remove or edit files. If possible, please add a row to the table below to allow easy access to your slides.
...
1/9/14 | LGSR | Joe | Antimicrobial PKPD IDM_clinpharm_Standing_2014.pdf |
8/9/14 meeting starts 2pm | Levinski | Julie | DDMore language |
15/9/14 | LGSR | Paul | Pharmacogenetics of diclofenac |
22/9/14 | LGSR | Yucheng | Count data models and introduction to Pirana |
29/9/14 | LGSR | Andreas | Gabapentin PKPD in paediatric neuropathic pain |
6/10/14 | LGSR | Liana | Tyrosine kinase inhibitor effects in polycystic kindney disease |
13/10/14 | LGSR | Joanna |
|
20/10/14 | LGSR | Rollo | Short-term neutrophil and lymphocyte HSCT models |
27/10/14 | LGSR | Eva | NeoGent PKUK practice |
3/11/14 | LGSR | Seb | Item Response Theory: Application to NLME |
10/11/14 | LGSR | Joe | A new mechanistic model for antiretroviral pharmacodynamics |
17/11/14 | LGSR | Alberto | Anaesthesia depth with 3 different EEG measures |
24/11/14 | LGSR | Suzanne Reeves | Mechanisms underpinning antipsychotic sensitivity in Alzheimer's disease |
1/12/14 | LGSR | Deji | Mixed Effect Modelling in Hep C-HIV coinfected children |
8/12/14 meeting starts at 2pm | LGSR | TBC | To be confirmed |
15/12/14 | LGSR | Morris | Understanding the determinants of drug exposure and pharmacokinetic variability in tuberculosis patients |
...
Date | Location* | Presenter | Topic |
|---|---|---|---|
| 12/1/15 | PUW3 | Lynette Phee | Modelling antimicrobial synergy |
| 19/1/15 | PUW3 | Michael Betancourt | Bayesian approaches in NLMEM |
| 26/1/15 | PUW4 | Deji | pre-Upgrade Talk |
| 2/2/15 | PUW3 | Joe | Study design peer review/journal club |
| 9/2/15 | PUW3 | Eva | Comparing methods for paediatric PK scaling |
| 16/2/15 | PUW3 | Ajay Sinha | Amikacin and Vancomycin PK in neonates |
| 23/2/15 | PUW4 | Julie | Joint modeling of Tenofovir plasmatic and intracellular concentrations - The COPHAR3 trial |
| 2/3/15 | PUW3 | Karin Seifert | Establishing PK/PD relationships of anti-leishmanial drugs |
| 9/3/15 | PUW3 | Joe | Antimicrobial PKPD, refresher and future directions |
| 16/3/15 | PUW3 | Sophie | Vaccine dyamics with NLME |
| 23/3/15 | PUW4 | Suzanne | Amisulpride PKPD |
| 30/3/15 | PUW3 | Morris | Determinants of variability in drug exposure and implications for dose selection in tuberculosis patients |